The complaint filed by Pomerantz LLP centers on a dramatic market manipulation campaign that allegedly utilized social media misinformation and impersonators posing as financial professionals. Shortly after the company’s initial public offering, Park Ha stock experienced a meteoric rise, climbing from an IPO price of $4.00 to a peak of $41.49 on July 7, 2025. This surge occurred despite a lack of material corporate developments or legitimate business activity to support the valuation.
Investors Face Deadline in Park Ha Securities Fraud Lawsuit
A federal class action lawsuit targets Park Ha Biological Technology following allegations that the company’s stock price was artificially inflated through a sophisticated pump-and-dump scheme. Investors who purchased shares during the class period now face a September 28, 2026, deadline to petition the court for lead plaintiff status.
Legal filings suggest the spike was fueled by a coordinated buying frenzy among retail investors, triggered by false endorsements in online forums and chat groups. The lawsuit seeks to hold the company and its leadership accountable for these practices. Investors seeking to participate in the litigation are instructed to contact Danielle Peyton at Pomerantz LLP by emailing dpeyton@pomlaw.com or calling 646-581-9980.
Comments (0)
No comments yet. Be the first!